This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Updates to this page
Published 16 December 2021 Last updated 16 October 2024 +show all updates
Updated to add: Doxorubicin 2mg/ml concentrate for solution.
Updated to add and remove products from the list. Added: Cresemba 200mg powder for concentrate for solution for infusion vials - Isavuconazole 200mg powder for solution for infusion vials. Removed: Comirnaty Omicron XBB.1.5 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection single dose vials; and HyQvia 2.5g/25ml solution for infusion and 1.25ml vials - Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials.
Updated to add: Temodal 100mg capsules - Temozolomide 100mg capsules.
Updated to add and remove products. Added: Colobreathe 1,662,500 unit inhalation powder capsules - Colistimethate 1,662,500unit inhalation powder capsules; and Spikevax JN.1 0.1 mg/mL dispersion for injection mRNA-1273.167 - COVID-19 mRNA vaccine. Removed: Brivaracetam 75mg tablets.
Updated to add and remove products. Added: Pegasys 90micrograms/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 90micrograms/0.5ml solution for injection pre-filled syringes; Remsima 100mg powder for concentrate for solution for infusion vials - Infliximab 100mg powder for concentrate for solution for infusion vials; Truxima 500mg/50ml concentrate for solution for infusion vials - Rituximab 500mg/50ml concentrate for solution for infusion vials. Removed: Cresemba 200mg powder for concentrate for solution for infusion vials - Isavuconazole 200mg powder for solution for infusion vials.
Updated to add products to the list. Added: Eklira 322micrograms/dose Genuair - Aclidinium bromide 375micrograms/dose dry powder inhaler; and HyQvia 2.5g/25ml solution for infusion and 1.25ml vials - Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials.
Updated to add and remove products. Added: Truxima 100mg/10ml concentrate for solution for infusion vials - Rituximab 100mg/10ml solution for infusion vials; Yuflyma 40mg/0.4ml solution for injection pre-filled pens - Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices; Oseltamivir 30mg capsules; Oseltamivir 45mg capsules; Oseltamivir 75mg capsules; and Dacarbazine 1g powder for solution for infusion vials. Removed: Zonegran 25mg capsules - Zonisamide 25mg capsules.
Added: perflutren-containing lipid microspheres 150 microlitres/ml gas and solvent for dispersion for injection/infusion.
Updated to add products to the list: Pegasys 135micrograms/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 135micrograms/0.5ml solution for injection pre-filled syringes; and Pegasys 180micrograms/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 180micrograms/0.5ml solution for injection pre-filled syringes.
Changed date in the date added column from 12 July 2027 to 12 July 2024 for 2 products: Spexotras 50micrograms/ml oral solution - Trametinib 50micrograms/ml oral solution sugar free and Voxelotor 500mg tablets.
Added to the list:Mounjaro KwikPen 15mg/0.6ml solut
